[go: up one dir, main page]

UA94056C2 - Застосування специфічних молочнокислих бактерій для одержання імуномодулюючих композицій - Google Patents

Застосування специфічних молочнокислих бактерій для одержання імуномодулюючих композицій

Info

Publication number
UA94056C2
UA94056C2 UAA200802594A UAA200802594A UA94056C2 UA 94056 C2 UA94056 C2 UA 94056C2 UA A200802594 A UAA200802594 A UA A200802594A UA A200802594 A UAA200802594 A UA A200802594A UA 94056 C2 UA94056 C2 UA 94056C2
Authority
UA
Ukraine
Prior art keywords
lactic acid
acid bacteria
obtaining
specific lactic
immunomodulatory compositions
Prior art date
Application number
UAA200802594A
Other languages
English (en)
Russian (ru)
Inventor
Джанкарла Донді
Патріція Мальфа
Original Assignee
Продже Фарм С.Р.Л.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Продже Фарм С.Р.Л. filed Critical Продже Фарм С.Р.Л.
Publication of UA94056C2 publication Critical patent/UA94056C2/uk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/179—Sakei

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Polymers & Plastics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Transplantation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Винахід належить до застосування лактобактерій штамів Lactobacillus salivarius I 1794 та Lactobacillus paracasei I 1688 для одержання композиції, придатної для модулювання імунної системи, де зазначені бактерії стимулюють утворення специфічних цитокінів.
UAA200802594A 2005-08-02 2006-07-31 Застосування специфічних молочнокислих бактерій для одержання імуномодулюючих композицій UA94056C2 (uk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT001510A ITMI20051510A1 (it) 2005-08-02 2005-08-02 Uso di specifici batteri lattici per la preparazione di composizioni iunomodulanti
PCT/IB2006/002080 WO2007015132A2 (en) 2005-08-02 2006-07-31 Use of specific lactic bacteria for the preparation of immunomodulating compositions

Publications (1)

Publication Number Publication Date
UA94056C2 true UA94056C2 (uk) 2011-04-11

Family

ID=37433818

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200802594A UA94056C2 (uk) 2005-08-02 2006-07-31 Застосування специфічних молочнокислих бактерій для одержання імуномодулюючих композицій

Country Status (8)

Country Link
US (2) US20090104168A1 (uk)
EP (1) EP1915058B1 (uk)
CA (1) CA2617352C (uk)
ES (1) ES2542963T3 (uk)
IT (1) ITMI20051510A1 (uk)
RU (1) RU2415920C2 (uk)
UA (1) UA94056C2 (uk)
WO (1) WO2007015132A2 (uk)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2378839T3 (es) 2008-05-16 2012-04-18 Nestec S.A. Lactobacillus paracasei y control del peso
TWI418356B (zh) * 2009-12-23 2013-12-11 Lytone Enterprise Inc 可作為免疫調節劑之副乾酪乳酸桿菌ｌｔ１２
IT1405395B1 (it) * 2010-08-05 2014-01-10 Proge Farm Srl Composizioni di probiotici e oli e loro uso.
US8980289B2 (en) 2010-08-31 2015-03-17 Niigata University Intestine immunomodulator
ITMI20122270A1 (it) 2012-12-31 2014-07-01 Giovanni Mogna Terapia di supporto ai trattamenti di chemioterapia per i tumori, per la sindrome da immunodeficienza acquisita e per le leucemie.
US10028983B2 (en) * 2013-02-22 2018-07-24 The Regents Of The University Of California Compositions and methods for promoting growth of beneficial microbes to treat or prevent disease or prolong life
US10413577B2 (en) 2013-02-22 2019-09-17 The Regents Of The University Of California Compositions and methods for promoting growth of beneficial microbes to treat or prevent disease or prolong life
US11077153B2 (en) 2014-05-05 2021-08-03 Chiara Benassai et al. Composition for use in treating or preventing viral or bacterial infections in a subject undergoing anti-tumor chemotherapy, leukemia treatment or aids therapy comprising L. reuteri LER03 and/or L. salivarius LS06
US10413576B2 (en) * 2014-05-05 2019-09-17 Giovanni Mogna Therapy for use in the treatment of tumors, acquired immunodeficiency syndrome and leukemias by dual immune biostimulation
IT201900000801A1 (it) * 2019-01-18 2020-07-18 Proge Farm Srl Composizione comprendente batteri probiotici non vitali e suo uso in terapia

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1289984B1 (it) 1997-02-27 1998-10-19 Proge Farm Srl Ceppi di lattobacilli utili nel trattamento di disfunzioni del sistema gastrointestinale
ID29150A (id) * 1999-01-15 2001-08-02 Entpr Ireland Cs Penggunaan lactobacillus salivarius

Also Published As

Publication number Publication date
US20090104168A1 (en) 2009-04-23
ITMI20051510A1 (it) 2007-02-03
CA2617352A1 (en) 2007-02-08
EP1915058B1 (en) 2015-05-20
CA2617352C (en) 2016-05-03
WO2007015132A2 (en) 2007-02-08
WO2007015132A3 (en) 2008-06-12
EP1915058A2 (en) 2008-04-30
RU2415920C2 (ru) 2011-04-10
WO2007015132A9 (en) 2008-03-20
ES2542963T3 (es) 2015-08-13
RU2008107935A (ru) 2009-09-10
US20120052050A1 (en) 2012-03-01

Similar Documents

Publication Publication Date Title
UA94056C2 (uk) Застосування специфічних молочнокислих бактерій для одержання імуномодулюючих композицій
NZ593708A (en) Compositions comprising probiotic and prebiotic components and mineral salts, with lactoferrin
MX2022003373A (es) Composiciones a base de cepas bacterianas y su uso como antiinflamatorios.
MX2008006546A (es) Bifidobacteria productora de ácido fólico, composición alimenticia y uso de la bifidobacteria.
ITMI20051509A1 (it) Ceppi di bifidobacterium produttori di acido folico loro formulazioni e uso
MX338201B (es) Bacterias acidolacticas de postacidificion baja.
UA93542C2 (uk) Штам молочнокислих бактерій streptococcus thermophilus, що забезпечує поліпшену текстуру ферментованих продуктів
NZ598751A (en) Anti-obesity agent, anti-obesity food or beverage, glucose tolerance-ameliorating agent, and food or beverage for amelioration of glucose tolerance (bifidobacterium breve mcc1274 (ferm bpp-11175))
MX2012005524A (es) Cepa de probioticos bifidobacterium.
HK1090289A1 (en) Antiallergic composition
MX2022003375A (es) Composiciones a base de cepas bacterianas y extractos de bayas y su uso como antinflamatorios.
IL173692A0 (en) Bacterial strains, compositions including same and probiotic use thereof
IL156490A0 (en) Probiotic compounds derived from lactobacillus casei strain ke01
GB2460781A (en) Probiotic bifidobacterium strains
UA93911C2 (uk) Застосування бактеріального штаму lactobacillus reuteri dsm 17938 для зниження колік у немовлят
IL181601A0 (en) Ferulate esterase producing strains and methods of using same
UA100551C2 (en) Synbiotic mixture
NZ601532A (en) Method for constructing novel bacterium belonging to the genus bifidobacterium
ATE367821T1 (de) Folsäure produzierende bifidobacterium bakterienstämme, ihre formulierungen und verwendung
MX2010005453A (es) Preparacion que contiene bacteria de acido lactico.
PL2561880T3 (pl) Bakterie kwasu mlekowego jako szczepy probiotyczne oraz kompozycje je zawierające
RS54837B1 (sr) Upotreba streptococcus salivarius u lečenju hroničnih infekcija respiratornog trakta
MXPA04005002A (es) Bacterias lacticas y su uso en el tratamiento y la prevencion del cancer.
MX2007004880A (es) Cepas de streptococcus thermophilus deficientes en aminopterina, con post-acidificacion reducida.
WO2008002484A3 (en) Novel lactobacillus bulgaricus strain and compositions